Noss, co-executive director of the Conservation Biology Institute in Corvallis, Ore., a professor of biology at Oregon State University and science editor for Wild Earth magazine, received the Natural Resources Council’s 1995 publication award for Saving Nature’s Legacy. He also co-authored The Science of Conservation Planning (Island Press, 1997). In 1993, he received a Pew Fellowship in conservation and the environment, and in 1995 he received the Edward T. LaRoe Memorial Award, the highest honor of the Society for Conservation Biology. His 27 years in environmental studies includes work with the Ohio Department of Natural Resources, the Nature Conservancy and the U.S. Environmental Protection Agency.

Under the auspices of The Bates College Merck Fellowhsip Program in Biology and Chemistry, Merck will discuss The Invention and Development of CRIXIVAN: An HIV Protease Inhibitor at 4 p.m. in Room 204 of Carnegie Science Hall. He will deliver his second lecture of the day, AIDS Therapy: The Power of Combination Treatments, at 7 p.m. in Chase Hall Lounge. Geared more toward a general audience, this second talk will address the increased effectiveness of anti-HIV and anti-AIDS drugs when used together.

Dorsey is part of the Merck research team that developed CRIXIVAN, an effective drug in the protease inhibitor class used to combat HIV, the virus that causes AIDS.